PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Australian National Phenome Center, and Center for Computational and Systems Medicine, Health Futures Institute, Murdoch University, Harry Perkins Building, Perth 6150, Western Australia, Australia.\', \'Bruker Biospin GmbH, Silberstreifen, Ettlingen 76275, Germany.\', \'Department of Cardiology, Fiona Stanley Hospital, Medical School, University of Western Australia, Perth 6150, Western Australia, Australia.\', \'Department of Endocrinology and Diabetes, Fiona Stanley Hospital, Medical School, University of Western Australia, Perth 6150, Western Australia, Australia.\', \'Precision Medicine and Metabolism Laboratory, CIC bioGUNE, Parque Tecnológico de Bizkaia, Bld. 800, 48160 Derio, Spain.\', \'Department of Metabolism, Digestion and Reproduction, Faculty of Medicine, Imperial College London, Sir Alexander Fleming Building, South Kensington, London SW7 2AZ, U.K.\', \'Chemistry Department, Universidad del Valle, 76001 Cali, Colombia.\', \'Institute of Global Health Innovation, Faculty of Medicine, Imperial College London, Level 1, Faculty Building, South Kensington Campus, London SW7 2NA, U.K.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.1021/acs.analchem.1c05389
?:hasPublicationType
?:journal
  • Analytical chemistry
is ?:pmid of
?:pmid
?:pmid
  • 35230805
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 2.362
?:rankingScore_hIndex
  • 295
is ?:relation_isRelatedTo_publication of
?:title
  • Exploration of Human Serum Lipoprotein Supramolecular Phospholipids Using Statistical Heterospectroscopy in n-Dimensions (SHY-n): Identification of Potential Cardiovascular Risk Biomarkers Related to SARS-CoV-2 Infection.
?:type
?:year
  • 2022

Metadata

Anon_0  
expand all